Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis

Clinical and Experimental Immunology

Volumn 142, Issue 3, 2005, Pages 576-584

  Fevang, Børre ^a   Mollnes, T E ^a   Holm, A M ^a   Ueland, T ^a   Heggelund, L ^a   Damas, J K ^a   Aukrust, P ^a   Froland' S S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Bronchiectasis; Complement; Immune deficiency syndromes; Mannose binding lectin; Respiratory tract infections

Indexed keywords

IMMUNOGLOBULIN; MANNOSE BINDING LECTIN;

ADULT; ARTICLE; AUTOIMMUNITY; BRONCHIECTASIS; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BRONCHIECTASIS; C-REACTIVE PROTEIN; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT C5A; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; LECTINS; MALE; MANNOSE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS;

EID: 28344455122     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02951.x     Document Type: Article

References (35)

1. Rosen FS, Eibl MM, Roifman CM et al. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Int Union Immunol Societies Clin Exp Immunol 1999;118:1-28.
2. Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344:1058-66.
3. Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344:1140-4.
4. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
5. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Meth 2000; 241:33-42.
6. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003; 40:73-84.
7. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Brit Med J 1997; 314: 1229-32.
8. Cedzynski M, Szemraj J, Swierzko AS et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004; 136:304-11.
9. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency. J Exp Med 2004; 199:1391-9.
10. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40:423-9.
11. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004; 351:260-7.
12. Andersen P, Permin H, Andersen V et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 2005; 105:511-7.
13. Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000; 51:111-22.
14. Soto ME, Cordera F, Reyes PA. Congenital C2 (type I) deficiency associated with common variable immunodeficiency. Ann Intern Med 2000; 132:597.
15. Sanal O, Yel L, Tezcan I, Ersoy F, Berkel AI. Homozygous C2 deficiency: association with defective alternative pathway function and immunoglobulin deficiency. Int Arch Allergy Immunol 1996; 110:195-8.
16. Aukrust P, Froland SS, Muller F. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 1992; 89:211-6.
17. Munro NC, Cooke JC, Currie DC, Strickland B, Cole PJ. Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production. Thorax 1990; 45:135-9.
18. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis 2004; 8:691-702.
19. Aukrust P, Aandahl EM, Skalhegg BS et al. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. J Immunol 1999; 162:1178-85.
20. Wu TL, Tsao KC, Chang CP, Li CN, Sun CF, Wu JT. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 2002; 322:163-8.
21. Mollnes TE, Lea T, Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22:197-202.
22. Mollnes TE, Redl H, Hogasen K et al Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol 1993; 91:295-300.
23. Seelen MA, Roos A, Wieslander J et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Meth 2005; 296:187-98.
24. Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 2002; 187:1313-20.
25. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358:637-8.
26. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614-8.
27. Dean MM, Minchinton RM, Heatley S, Eisen DP. Mannose Binding Lectin Acute Phase Activity in Patients with Severe Infection. J Clin Immunol 2005; 25:346-52.
28. Carlsson M, Sjoholm AG, Eriksson L et al. Deficiency of the man-nan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relation-ship. Clin Exp Immunol 2005; 139:306-13.
29. Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Froland SS. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 32:354-61.
30. Schafranski MD, Stier A, Nisihara R, Messias-Reason IJ. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 2004; 138:521-5.
31. Koch A, Melbye M, Sorensen P et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. J Am Med Assoc 2001; 285:1316-21.
32. Garred P, Pressler T, Madsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104:431-7.
33. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. Brit Med J 1999; 319:1166-7.
34. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17:532-40.
35. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003; 31:753-7.